Your browser doesn't support javascript.
loading
The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.
Schorcht, Anna; Cottrell, Christopher A; Pugach, Pavel; Ringe, Rajesh P; Han, Alvin X; Allen, Joel D; van den Kerkhof, Tom L G M; Seabright, Gemma E; Schermer, Edith E; Ketas, Thomas J; Burger, Judith A; van Schooten, Jelle; LaBranche, Celia C; Ozorowski, Gabriel; de Val, Natalia; Bader, Daniel L V; Schuitemaker, Hanneke; Russell, Colin A; Montefiori, David C; van Gils, Marit J; Crispin, Max; Klasse, P J; Ward, Andrew B; Moore, John P; Sanders, Rogier W.
Afiliación
  • Schorcht A; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • Cottrell CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Pugach P; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, USA.
  • Ringe RP; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, USA.
  • Han AX; Laboratory of Applied Evolutionary Biology, Department of Medical Microbiology and Infection Prevention, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • Allen JD; Centre for Biological Sciences and Institute for Life Sciences, University of Southamptongrid.5491.9, Southampton, England, United Kingdom.
  • van den Kerkhof TLGM; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • Seabright GE; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • Schermer EE; Centre for Biological Sciences and Institute for Life Sciences, University of Southamptongrid.5491.9, Southampton, England, United Kingdom.
  • Ketas TJ; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • Burger JA; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, USA.
  • van Schooten J; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • LaBranche CC; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • Ozorowski G; Department of Surgery, Duke Universitygrid.26009.3d Medical Center, Durham, North Carolina, USA.
  • de Val N; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Bader DLV; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Schuitemaker H; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Russell CA; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • Montefiori DC; Laboratory of Applied Evolutionary Biology, Department of Medical Microbiology and Infection Prevention, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • van Gils MJ; Department of Surgery, Duke Universitygrid.26009.3d Medical Center, Durham, North Carolina, USA.
  • Crispin M; Department of Medical Microbiology and Infection Prevention, Amsterdam Infection & Immunity Institute (AI&AII), Amsterdam UMC, Location Meibergdreef, University of Amsterdam, Amsterdam, The Netherlands.
  • Klasse PJ; Centre for Biological Sciences and Institute for Life Sciences, University of Southamptongrid.5491.9, Southampton, England, United Kingdom.
  • Ward AB; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, USA.
  • Moore JP; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Sanders RW; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, USA.
J Virol ; 96(1): e0155221, 2022 01 12.
Article en En | MEDLINE | ID: mdl-34669426
ABSTRACT
The human immunodeficiency virus type 1 (HIV-1) trimeric envelope glycoprotein (Env) is heavily glycosylated, creating a dense glycan shield that protects the underlying peptidic surface from antibody recognition. The absence of conserved glycans, due to missing potential N-linked glycosylation sites (PNGS), can result in strain-specific, autologous neutralizing antibody (NAb) responses. Here, we sought to gain a deeper understanding of the autologous neutralization by introducing holes in the otherwise dense glycan shields of the AMC011 and AMC016 SOSIP trimers. Specifically, when we knocked out the N130 and N289 glycans, which are absent from the well-characterized B41 SOSIP trimer, we observed stronger autologous NAb responses. We also analyzed the highly variable NAb responses induced in rabbits by diverse SOSIP trimers from subtypes A, B, and C. Statistical analysis, using linear regression, revealed that the cumulative area exposed on a trimer by glycan holes correlates with the magnitude of the autologous NAb response. IMPORTANCE Forty years after the first description of HIV-1, the search for a protective vaccine is still ongoing. The sole target for antibodies that can neutralize the virus are the trimeric envelope glycoproteins (Envs) located on the viral surface. The glycoprotein surface is covered with glycans that shield off the underlying protein components from recognition by the immune system. However, the Env trimers of some viral strains have holes in the glycan shield. Immunized animals developed antibodies against such glycan holes. These antibodies are generally strain specific. Here, we sought to gain a deeper understanding of what drives these specific immune responses. First, we show that strain-specific neutralizing antibody responses can be increased by creating artificial holes in the glycan shield. Second, when studying a diverse set of Env trimers with different characteristics, we found that the surface area of the glycan holes contributes prominently to the induction of strain-specific neutralizing antibodies.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Polisacáridos / Infecciones por VIH / VIH-1 / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Multimerización de Proteína Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Virol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Polisacáridos / Infecciones por VIH / VIH-1 / Productos del Gen env del Virus de la Inmunodeficiencia Humana / Multimerización de Proteína Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Virol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos